Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,322
Sort by:
Beneluxian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Beneluxian market for dental bone graft substitutes and other biomaterials, which includes Belgium, the Netherlands and Luxemburg, was the seventh largest in Europe in 2008. The Netherlands represented the vast majority of this market, which grew significantly in 2007. The rapid growth in the number of ...
September 2009
70 pages
French Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the French market for dental bone graft substitutes was the fourth largest in Europe. The 2008 average selling price for dental ... higher material costs and a lack of government and private insurance coverage. The French market will continue to see double digit growth driven by an increasing number of ...
September 2009
70 pages
Polish Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Polish market for dental bone graft substitutes and other biomaterials was the ninth largest in Europe. In 2008, growth in the number of ... implant procedures well into double digit rates over the forecast period. Poland is also associated with greater use of mineralized allografts, bolstered by demand for ...
September 2009
70 pages
Swiss Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Swiss market for dental bone graft substitutes and other biomaterials grew at double digit rates. While Switzerland has a relatively small population, it has one of the highest dental implant per capita rates in Europe, driving bone graft substitute use. ...
September 2009
70 pages
U.K. Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The U.K. market for dental bone graft substitutes and other biomaterials was the sixth largest in Europe in 2008. The market growth rate is predicted to be well above the European average over the forecast period. Average selling prices for dental bone ...
September 2009
70 pages
Global Biomaterial Market (2009-2014)
US$ 5,650.00
... global biomaterial market as follows: Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others Biomaterials ingredient market Metals, polymers, ceramics, composites Biomaterials application market ...
September 2009
256 pages
Biosimilars (2009 - 2014)
US$ 5,650.00
... numerous opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into ... of the global biosimilars market. The American market is expected to dominate in 2014 after the U.S. market opens up in 2010. Currently, the global biosimilars market is highly ...
September 2009
189 pages
Roche & Genentech: a Model for Future Biotech Deals?
US$ 295.00
Could this single deal mark a phase of big pharma/biotech consolidation? In March 2009, after months of negotiations, Roche acquired the 44 percent of shares that it did not already own in its long-t...
August 2009
42 pages
Bioterrorism: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, Asia, ... Baker Company, Universal Detection Technology and Universal Detection Technology. Market data and analytics are derived from primary and secondary ...
July 2009
273 pages
Branded Generics: Strategies and Tactics for Winning in Latin America
US$ 1,995.00
... …but in Mexico it’s the small companies that have done well in generics.” Xavier Tello, Independent healthcare industry expert “As a manufacturer, you should ... in hospital-driven niches, such as oncology Branded Generics: Strategies and Tactics for Winning in Latin America answers key questions: Who are ...
March 2009
71 pages
U.S. Market for Orthopedic Bioabsorbable Bone Pins and Screws 2009
US$ 7,495.00
The orthopedic bioabsorbable bone pins and screws market includes resorbable shoulder, ACL/PCL, meniscus, and fracture fixation devices. Over the forecast period, unit sales, average selling prices and total market value are estimated to increase steadily.
March 2009
66 pages
Stem Cell Therapeutics Markets
US$ 2,500.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. C...
February 2009
150 pages
Production, Market and Benchmarking of Biotin in China
US$ 14,897.00
... looks into the development history, production, import/export, consumption, technology innovation and the benchmarking of biotin in China. Meanwhile, this report also researches ...
September 2008
86 pages
Asia-Pacific Markets for Spinal Implants, VCF, and Biomaterials 2008 (5 countries)
US$ 8,495.00
... in Australia, China, Japan, South Korea and Taiwan. In 2006, the Asia-Pacific market for spinal implants and biomaterials was valued at over $500 million. The majority ... growth in the near future but growth of the non-fusion and VCF markets will help drive double digit growth rates of the total market. By 2013 ...
October 2007
215 pages
Biotin Market Research (China)
US$ 2,700.00
... of the two parts. In the part of production & market information, the situation of biotin has been introduced and discussed from aspects of history ... technology, production, market, import & export, consumption, etc. Great effort is made in analyzing the import & export situation of biotin from 2002-2004 ...
June 2006
73 pages
